Clinical considerations related to hydrocodone rescheduling

UPDATE AND CORRECTION: After the Academy issued its advice to clinicians and patients regarding refills of hydrocodone-containing combination products (HCCP), the US Drug Enforcement Administration (DEA) issued a clarification of its rules concerning refills of existing prescriptions for these products. The DEA has determined that existing prescriptions for HCCP with remaining refills may be refilled […]

Rational polypharmacy for patients with chronic pain

Combining medications is a popular strategy in the treatment of people with chronic pain, but clinicians must be mindful of the pharmacokinetic risks, according to Dr. Jeffrey Fudin, clinical pharmacy specialist at the Stratton VA Medical Center in Albany, New York.  Dr. Fudin, who spoke at the American Academy of Pain Management’s 25th annual clinical […]

An ethical paradox for pain practitioners: objectivity vs. subjectivity

Should doctors trust their patients?  This was the topic explored by Peter A. Moskovitz, MD, Clinical Professor of Orthopedic Surgery and Neurology Surgery, in his keynote address at the 2014 annual clinical meeting of the American Academy of Pain Management.  While it’s true that patients can mislead doctors, whether intentionally or not, an objective diagnosis […]

Noninvasive devices may help migraines, FDA says

Excerpt: Two new prescription devices approved by the U.S. Food and Drug Administration (FDA) may provide some relief for people with migraine headaches who don’t tolerate migraine medications well, according to a new study.  One device — the Cefaly — is designed to prevent migraines, while the other device — the Cerena — is meant […]

FDA approves Movantik for opioid-induced constipation

Excerpt: The U.S. Food and Drug Administration has approved Movantik (naloxegol), an oral treatment for opioid-induced constipation in adults with chronic non-cancer pain. [...]  Movantik’s safety and effectiveness were established in two clinical trials of 1,352 participants who had taken opioids for at least four weeks for non-cancer related pain and had opioid-induced constipation.

Living in a disadvantaged neighborhood worsens musculoskeletal pain outcomes after trauma exposure

A year-long study has shown that individuals living in disadvantaged neighborhoods have worse musculoskeletal pain outcomes over time after motor vehicle collision than individuals from higher socioeconomic status neighborhoods, even after accounting for a slew of individual characteristics.  The study, which enrolled 948 European-Americans in four different areas across the country, enrolled patients at the […]